NAGESHWARA V. DASARI to Dose-Response Relationship, Drug
This is a "connection" page, showing publications NAGESHWARA V. DASARI has written about Dose-Response Relationship, Drug.
Connection Strength
0.028
-
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer. Invest New Drugs. 2013 Apr; 31(2):345-54.
Score: 0.014
-
Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors. J Clin Oncol. 2012 Jul 01; 30(19):2348-53.
Score: 0.014